Share Name Share Symbol Market Type
Johnson and Johnson NYSE:JNJ NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -2.37 -1.44% 162.50 164.49 158.26 164.49 14,087,602 01:00:01

F-star Therapeutics Shares Up 9% Premarket After Janssen Biotech Deal

20/10/2021 1:58pm

Dow Jones News

Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart

From Jul 2021 to Jan 2022

Click Here for more Johnson and Johnson Charts.

By Chris Wack


F-star Therapeutics Ltd. shares were up 9% to $6.96 in premarket trading Wednesday after the biopharmaceutical company said it entered into a license and collaboration agreement with Johnson & Johnson's Janssen Biotech Inc.

Under the terms of the agreement, F-star said it will grant Janssen a worldwide, exclusive royalty-bearing license to research, develop, and commercialize up to five novel bispecific antibodies directed to Janssen therapeutic targets using F-star's proprietary Fcab and mAb platforms.

Janssen will be responsible for all research, development, and commercialization activities under the agreement.

F-star said it is entitled to receive upfront fees of $17.5 million, and near-term fees and potential further milestones of up to $1.35 billion. F-star is also eligible to receive potential tiered mid-single digit royalties on annual net sales.


Write to Chris Wack at chris.wack@wsj.com


(END) Dow Jones Newswires

October 20, 2021 08:43 ET (12:43 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Johnson and Johnson Chart

1 Year Johnson and Johnson Chart

1 Month Johnson and Johnson Chart

1 Month Johnson and Johnson Chart
ADVFN Advertorial
Your Recent History
Johnson an..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220125 05:03:50